Sabina Chiaretti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol	LEUKEMIA & LYMPHOMA	2019
Minimal residual disease in acute lymphoblastic leukemia: technical and clinical advances	FRONTIERS IN ONCOLOGY	2019
in Ph+BCR-ABL1 acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent	SN APPLIED SCIENCES	2019
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients	ANNALS OF ONCOLOGY	2018
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.	BRITISH JOURNAL OF HAEMATOLOGY	2018
"Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL.	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2018
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.	ONCOIMMUNOLOGY	2018
Prognostic implications of additional genomic lesions in adult Ph+ acute lymphoblastic leukemia	HAEMATOLOGICA	2018
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies	LEUKEMIA & LYMPHOMA	2018
Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)	BONE MARROW TRANSPLANTATION	2018
Chemotherapy-free and reduced intensity approaches in elderly patients with B-lineage acute lymphoblastic leukemia	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2018
New Approaches to the Management of Adult Acute Lymphoblastic Leukemia	JOURNAL OF CLINICAL ONCOLOGY	2018
High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangement	LEUKEMIA	2018
Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts	BRITISH JOURNAL OF HAEMATOLOGY	2017
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments	BRITISH JOURNAL OF HAEMATOLOGY	2016
CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities	LEUKEMIA RESEARCH	2016
Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients	LEUKEMIA	2016
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes	ONCOTARGET	2016
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications	HAEMATOLOGICA	2016
Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia	HAEMATOLOGICA	2016

Progetti di Ricerca

Dissecting and redefining the interplay between minimal residual disease and genetic features of Ph-like ALL:
The BCR/ABL1-like acute lymphoblastic leukemia (ALL) predictor: refinement of clinical and biological features of BCR/ABL1-like ALL patients, and validation and reproducibility of the diagnostic method